TIRZ 20mg

Tirzepatide is a novel peptide drug that acts as a dual agonist of the GLP-1 and GIP receptors. It has been studied for the treatment of type 2 diabetes and obesity, showing significant improvements in blood sugar control and weight reduction in clinical trials.

Disclaimer: Tirzepatide is an experimental research chemical and is not approved for human consumption or medical use unless prescribed and dispensed through authorized channels. When sold for research purposes, it is intended strictly for laboratory research only. Any unauthorized use in humans or animals is strictly prohibited. The purchaser assumes all responsibility for proper handling and compliance with applicable laws and regulations.